Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.
Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, Alfonso F, Latib A, Ong PJ, Rissanen TT, Saucedo J, Scheller B, Kleber FX; International DCB Consensus Group.
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1391-1402. doi: 10.1016/j.jcin.2020.02.043. Epub 2020 May 27.
Definite stent thrombosis after drug-eluting stent implantation in coronary bifurcation lesions: A meta-analysis of 3,107 patients from 14 randomized trials.
Zhou Y, Chen S, Huang L, Hildick-Smith D, Ferenc M, Jabbour RJ, Azzalini L, Colombo A, Chieffo A, Zhao X.
Catheter Cardiovasc Interv. 2018 Oct 1;92(4):680-691. doi: 10.1002/ccd.27443. Epub 2017 Dec 7.
Drug-coated balloon in the treatment of coronary bifurcation lesions: A hope or hype?
Dash D, Mody R, Ahmed N, Malan SR, Mody B.
Indian Heart J. 2022 Nov-Dec;74(6):450-457. doi: 10.1016/j.ihj.2022.10.193. Epub 2022 Nov 5.
Contemporary use of drug-coated balloons in coronary artery disease: Where are we now?
Picard F, Doucet S, Asgar AW.
Arch Cardiovasc Dis. 2017 Apr;110(4):259-272. doi: 10.1016/j.acvd.2017.01.005. Epub 2017 Mar 6.
Single versus double stenting for unprotected left main coronary artery bifurcation lesions: a systematic review and meta-analysis.
Karrowni W, Makki N, Dhaliwal AS, Vyas A, Blevins A, Dughman S, Girotra S, Cram P, Horwitz PA.
J Invasive Cardiol. 2014 Jun;26(6):229-33.
Clinical outcomes of coronary artery bifurcation disease patients underwent Culotte two-stent technique: a single center experience.
Chang CF, Chang KH, Lai CH, Lin TH, Liu TJ, Lee WL, Su CS.
BMC Cardiovasc Disord. 2019 Sep 2;19(1):208. doi: 10.1186/s12872-019-1192-2.
The "L-Sandwich" Strategy for True Coronary Bifurcation Lesions: A Randomized Clinical Trial.
Guo Q, Peng L, Rao L, Ma C, Zhao K, Zhao Z, Tang H, Li M.
J Interv Cardiol. 2023 Mar 21;2023:6889836. doi: 10.1155/2023/6889836. eCollection 2023.
Safety and effectiveness of the self-aPposing, bAlloon-delivered, siRolimus-eluting stent for the Treatment of the coronary Artery disease: SPARTA, a multicenter experience.
Montefusco A, De Filippo O, Gili S, Mancone M, Calcagno S, Cirillo P, Esposito G, Poli A, Ferrara E, Smolka G, Wanha W, Palmieri C, Pastormerlo LE, Baumbach A, Sganzerla P, Tamburino C, Bruno F, Secco GG, Nicolino A, Yew KL, di Palma G, Wojakowski W, Sardella G, Rinaldi M, Cortese B, D'Ascenzo F.
Coron Artery Dis. 2020 Jan;31(1):27-34. doi: 10.1097/MCA.0000000000000790.
Application of Drug-Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions.
Somsen YBO, Rissanen TT, Hoek R, Ris TH, Stuijfzand WJ, Nap A, Kleijn SA, Henriques JP, de Winter RW, Knaapen P.
Catheter Cardiovasc Interv. 2025 Feb;105(2):494-516. doi: 10.1002/ccd.31316. Epub 2024 Dec 11.
Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
Kim YH, Dangas GD, Solinas E, Aoki J, Parise H, Kimura M, Franklin-Bond T, Dasgupta NK, Kirtane AJ, Moussa I, Lansky AJ, Collins M, Stone GW, Leon MB, Moses JW, Mehran R.
Am J Cardiol. 2008 Mar 15;101(6):801-6. doi: 10.1016/j.amjcard.2007.10.052. Epub 2008 Jan 18.
